期刊档案 · ALLERGYIMMUNOLOGY-IMMUNOLOGY
Journal of Allergy and Clinical Immunology-In Practice
ISSN 2213-2198 · eISSN 2213-2201 · Elsevier · NETHERLANDS
Journal of Allergy and Clinical Immunology-In Practice 中科院 医学 1区（2025 年升级版，Top 期刊），影响因子 7.1，混合开放获取，APC 约 4,000 美元，近 24 个月 107 篇文章投稿到接收中位 105 天，官网公布录用率 28%，2025 年发文 638 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Journal of Allergy and Clinical Immunology-In Practice 由 Elsevier 出版，属中科院医学大类（2025 升级版1区，Top 期刊）。按 OpenAlex 近年发文统计，该刊主要发表 Asthma and respiratory diseases、Food Allergy and Anaphylaxis Research、Allergic Rhinitis and Sensitization 等主题的论文，这 3 个主题约占 38.2%。（根据 OpenAlex 主题统计与中科院分区数据生成）
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), and a companion title to the field-leading The Journal of Allergy and Clinical Immunology. It brings timely clinical papers, instructive case reports, and the latest management recommendations to clinical allergists and other physicians concerned with clinical manifestations of allergic and immunologic diseases in their practice.Vision The vision of JACI: In Practice is to be an indispensable resource for clinicians who manage patients with asthma, allergic, immunologic, and related conditions in order to optimize the care and health of these patients.Mission The mission of JACI: In Practice is to provide novel, valid, generalizable, and impactful information to support evidence-based clinical decisions in the diagnosis and management of asthma, allergic, immunologic, and related conditions.AAAAI Journals Diversity Statement Equity and inclusion in publishing are critically important for scientific innovation and excellence. The AAAAI Journals value inclusion and diversity across research, through its various lenses, be it authors, reviewers, or editors. This is in line with the AAAAI Diversity Equity and Inclusion Statement as well as Elsevier's support of the joint commitment for action on inclusion and diversity in publishing. We are committed to multilevel initiatives to promote diversity, equity, and inclusion in the articles we publish and in the people who write, review, and edit them.Scope JACI: In Practice publishes clinically impactful articles on the spectrum of conditions treated by allergist-immunologists in their practice: food allergy, respiratory disorders (including asthma, allergic and nonallergic rhinitis/rhinoconjunctivitis, nasal polyps, chronic sinusitis, cough, allergic bronchopulmonary aspergillosis [ABPA], and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (including atopic dermatitis, contact dermatitis, urticaria, angioedema, and hereditary angioedema [HAE]), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The Journal emphasizes cutting edge practical clinical information for practitioners that they can use in everyday practice or will help them acquire new knowledge or skills they can directly apply to patient care. Mechanistic or translational studies without immediate or near future clinical relevance and animal studies are not within the scope of the Journal.Content All JACI: In Practice content is peer-reviewed. The Journal welcomes original research articles that fit into the above scope. For each Original Article, a highlight box indicates what is already known about this subject, what this study adds, and how the new information impacts current management guidelines. Shorter original research and instructive case reports are presented as Clinical Communications. "Images in Allergy" articles consist of clinical pictures (eg, X-rays, CT scans, biopsies, allergens, endoscopic visualizations of the airway, eruptions, etc.) and impart important clinical information. In addition, JACI: In Practice features various types of review articles that will primarily be invited by the editors. Many of these offer CME, and the invited Difficult Cases feature offers MOC credit. The original and review articles are supplemented by Editorials, AAAAI Practice Papers, Practice Options From Beyond Our Pages, Ask the Expert, and Practice Pearls features.Contact Us Editorial Office: inpractice@aaaai.org; Tel 720-446-2822 Editorial Manager submission site: https://www.editorialmanager.com/inpractice AAAAI: info@aaaai.org; Tel 414-272-6071
摘自期刊官网 Aims & Scope
研究方向（LetPub）：ALLERGYIMMUNOLOGY-IMMUNOLOGY
主编 Michael Schatz出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 55、澳大利亚 8、英国 6、加拿大 3、中国香港 2（共 90 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Asthma and respiratory diseasesMedicine16.4%
- Food Allergy and Anaphylaxis ResearchMedicine12.4%
- Allergic Rhinitis and SensitizationMedicine9.4%
- Drug-Induced Adverse ReactionsMedicine8%
- Contact Dermatitis and AllergiesMedicine5.2%
- Respiratory and Cough-Related ResearchMedicine4.8%
- Urticaria and Related ConditionsMedicine4.7%
- Eosinophilic EsophagitisMedicine4.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 免疫学IMMUNOLOGY | 1 区 |
| 小类 | 过敏ALLERGY | 2 区 |
Top 期刊：是综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 过敏ALLERGY | 1 区 |
| 小类 | 免疫学IMMUNOLOGY | 2 区 |
Top 期刊：是综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 1 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 1 区 |
| 小类 | 过敏ALLERGY | 1 区 |
| 小类 | 免疫学IMMUNOLOGY | 1 区 |
Top 期刊：是综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 7.1LetPub ·
- 影响因子（出版商公布）
- 7.2出版商官网 ·
- CiteScore 2026-06
- 9.6LetPub ·
- CiteScore（出版商公布）
- 9.6出版商官网 ·
- SJR 2026-06
- 1.77LetPub ·
- SNIP 2026-06
- 1.65LetPub ·
- h-index
- 40LetPub ·
- h-index
- 137OpenAlex ·
- i10-index
- 3,048OpenAlex ·
- 两年平均被引
- 3.81OpenAlex ·
- 自引率
- 11.1%LetPub ·
- Gold OA 文章占比
- 21.64%LetPub ·
发文规模
- 年文章数
- 288LetPub ·
逐年发文量 OpenAlex 统计 · 累计 7,475 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 427 | 170 | 193 |
| 2025 | 638 | 311 | 1,911 |
| 2024 | 668 | 306 | 4,507 |
| 2023 | 721 | 402 | 7,333 |
| 2022 | 656 | 353 | 9,528 |
| 2021 | 785 | 419 | 14,993 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
105 天投稿到接收中位数 · P25–P75 72 天 – 140 天
- 接收到上线
- 中位数 11 天（94 篇）
- 投稿到上线
- 中位数 123 天
- 样本
- 107 篇有投稿与接收日期的文章（窗口内共 1,028 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 录用率（出版商公布）
- 28%出版商官网 ·
- 投稿到首次决定
- 4 天出版商官网 ·
- 外审后首次决定
- 30 天出版商官网 ·
- 投稿到接收
- 87 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,000 / EUR 3,740 / GBP 3,200 / JPY 496,120 | — | — | |
| 出版商官网 | USD 4,000 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点6 项，摘自作者指南
- 摘要
- ≤ 250 词
- 正文篇幅
- ≤ 3,500 词
- 参考文献格式
- Vancouver 格式
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- Highlights（研究亮点）
- 必须提供
- 图文摘要
- 可选
接收的文章类型6 种，含篇幅限制
- case studyd be omitted if they are not essential. Case Studies in Health Disparities must: (1) Be no longer than 1000 words. (2) Have no more than two visual elements (ta…正文 ≤ 1,000 词
- clinical communicationsB. Clinical Communications. Clinical Communications are brief reports of clinical or laboratory observations or case series.未说明篇幅
- original articleThe Journal will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasible, …正文 ≤ 3,500 词
- original articlesA. Original articles. These articles should describe fully, but as concisely as feasible, the results of original clinical research.未说明篇幅
- reviewThe Journal will consider publication of several types of manuscripts:A. Original articles. These articles should describe fully, but as concisely as feasible, …未说明篇幅
- review articleplementation Science The formatting for Review Articles in this feature is as follows: The overall length of the manuscript should be limited to 3000 words (not…正文 ≤ 3,000 词
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- AI 使用 Declaration of generative AI in scientific writing
作者在投稿时必须声明在稿件准备过程中使用了生成式人工智能工具。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Authorship
根据国际医学期刊编辑委员会（ICMJE）的建议，署名作者必须满足四项条件：对研究的设计、数据获取或分析解释有实质性贡献；撰写或批判性审阅稿件；批准最终发表版本；并对工作的所有方面负责。 模型中文摘要
As recommended by the International Committee of Medical Journal Editors (ICMJE) (ICMJE | Recommendations | Defining the Role of Authors and Contributors), in order to be included in the list of authors on a manuscript, an individual must have done all of the following: (1) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) dra…
原文 ↗出版商官网 ·- 利益冲突 Conflict of Interest
所有作者必须披露本人及其直系亲属/重要他人的所有财务关系，并在稿件首页注明所有资助来源及可能构成利益冲突的商业关联。 模型中文摘要
All authors must disclose all financial relationships for themselves and their immediate family/significant others. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work and any commercial associations that might pose a conflict of interest. These include consultant arrangements, speakers' bureau participation, stock or …
原文 ↗出版商官网 ·- 数据可用性 Data sharing author instructions statement
该期刊支持数据共享，鼓励作者将数据存入公共存储库，并可在投稿时提供数据可用性声明（含存储库链接），该声明应写在稿件首页。 模型中文摘要
JACI: In Practice supports data sharing. Authors are encouraged to archive data in an appropriate public repository. Authors may provide a data availability statement with their submission, including a link to the repository they have used, to be published in their article. This statement should be included on the title page of the manuscript. Anyone using these shared data should cite the origina…
原文 ↗出版商官网 ·- 出版伦理
AAAAI期刊不考虑由烟草行业或从烟草行业获得大量资助的组织资助的研究或文章。 模型中文摘要
The AAAAI journals will not consider studies or articles funded by the tobacco industry or by organizations that receive substantial funding from the tobacco industry.
原文 ↗出版商官网 ·- 许可与版权 Copyright
文章被接受后，作者需签署期刊出版协议；订阅者可在机构内部传阅目录或摘要列表，但转售、机构外分发及其他衍生作品需获得出版商许可。 模型中文摘要
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of articles inclu…
原文 ↗出版商官网 ·- 开放获取 Open access
有关本期刊开放获取出版的更多信息，请访问开放获取页面。 模型中文摘要
Please visit our Open Access page for more information about open access publishing in this journal.
原文 ↗出版商官网 ·- 同行评审 Peer Review Process
所有稿件至少由一名编辑审阅；超出期刊范围或优先级较低的稿件可能不经同行评审即被拒；多数稿件由至少2名审稿人评估，必要时邀请生物统计学审稿人；同行评审为单盲，审稿人身份对作者保密。 模型中文摘要
All manuscripts are reviewed by at least one editor. Manuscripts may be rejected by the editor(s) without peer review due to being out of the journal scope or if they are determined to be low priority based on considerations such as novelty, validity, generalizability, and clinical impact. Manuscripts warranting further consideration are sent for peer review. Most manuscript are evaluated by at le…
原文 ↗出版商官网 ·- 查重
为验证原创性，文章可能会通过Crossref相似度检测服务进行检查。 模型中文摘要
To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
原文 ↗出版商官网 ·- 预印本 Preprints
该期刊允许已在预印本服务器发布的投稿；发表后作者须更新预印本并链接最终发表版本；若预印本已正式发表，应引用正式出版物；引用预印本时须明确标注并提供预印本DOI。 模型中文摘要
JACI: In Practice allows submissions that have been posted on preprint servers. Upon publication in our journal, authors are required to update their preprint article with a link to the final published version.Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If a preprint is used as a reference, it should be …
原文 ↗出版商官网 ·- 试验注册 / 报告规范 PRISMA guidelines for systematic reviews and meta-analyses
对于随机对照试验（RCT）的荟萃分析，鼓励作者参考PRISMA声明的建议。 模型中文摘要
For meta-analysis of RCTs, we encourage authors to consult the recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement, available at www.prisma-statement.org.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- NETHERLANDS
- 出版语言
- English
- ISSN
- 2213-2198
- 电子版 ISSN
- 2213-2201
- 学会 / 主办单位
- American Academy of Allergy
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Journal of Allergy and Clinical Immunology-In Practice 的常见问题
Journal of Allergy and Clinical Immunology-In Practice 是中科院几区期刊？
2025 年升级版分区表中，Journal of Allergy and Clinical Immunology-In Practice 为医学 1区，小类 免疫学 / 过敏 1 区，属于 Top 期刊。2026 年新锐版分区表中为医学 1区。不同版本与大小类分区不能混用。
Journal of Allergy and Clinical Immunology-In Practice 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 7.1，CiteScore 为 9.6，h-index 为 137。
Journal of Allergy and Clinical Immunology-In Practice 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）107 篇已发表文章登记的日期，投稿到接收的中位数为 105 天（四分位 72–140 天）；期刊官网公布的录用率为 28%。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Allergy and Clinical Immunology-In Practice 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；正文篇幅：≤ 3,500 词；参考文献格式：Vancouver 格式；首次投稿格式：允许不按期刊格式排版（free format）；Highlights：必须提供；图文摘要：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Allergy and Clinical Immunology-In Practice 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 90 位编委中，没有中国大陆学者；人数最多的国家是 美国（55 位）、澳大利亚（8 位）、英国（6 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Allergy and Clinical Immunology-In Practice 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Allergy and Clinical Immunology-In Practice 被 SCIE、Scopus 收录。
Journal of Allergy and Clinical Immunology-In Practice 是开放获取期刊吗？版面费多少？
Journal of Allergy and Clinical Immunology-In Practice 为混合开放获取。选择开放获取发表时APC 约 4,000 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。